These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9638219)

  • 1. [Anxiety-depressive neurosis in ambulatory treatment conditions].
    Roś LT
    Wiad Lek; 1995; 48(1-12):111-6. PubMed ID: 9638219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the usefulness and effectiveness of anxiolytic therapies in neoplastic diseases].
    Ziółko E; Knopik J; Bucior J; Foltyn W; Jastrzebska-Okoń K; Tomczyk A; Kempiński M
    Pol Merkur Lekarski; 2004 Jun; 16(96):561-4. PubMed ID: 15510897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacologic correction of psycho-emotive disorders in the rehabilitation of patients after removal of brain tumors].
    Koval'chuk VV
    Vopr Onkol; 2007; 53(6):704-10. PubMed ID: 18416142
    [No Abstract]   [Full Text] [Related]  

  • 4. Cognitive style, alprazolam plasma levels, and treatment response in panic disorder.
    Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
    Depress Anxiety; 2008; 25(8):E18-26. PubMed ID: 17960759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind clinical study comparing alprazolam and doxepin in primary unipolar depression.
    Ansseau M; Ansoms C; Beckers G; Bogaerts M; Botte L; De Buck R; Diricq S; Dumortier A; Jansegers E; Owieczka J
    J Affect Disord; 1984 Dec; 7(3-4):287-96. PubMed ID: 6151958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical use of sustained release of alprazolam: A naturalistic study].
    De La Gándara Martín JJ; Sanz Granado O; Varona Martínez A; Such P
    Actas Esp Psiquiatr; 1999; 27(3):191-7. PubMed ID: 10431062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alprazolam (Xanax, and others) revisited.
    Med Lett Drugs Ther; 2005 Jan; 47(1200):5-7. PubMed ID: 15647704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxepin in the inpatient treatment of depressive states.
    Ciureza T; Tudorache D; Ionescu R; Niţurad A; Nica S; Oproiu L; Popovici I; Roman I; Curelaru S; Ionescu R
    Rev Roum Neurol Psychiatr; 1974; 11(3):249-52. PubMed ID: 4846959
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anxiety disorders in private practice psychiatric out-patients: prevalence, comorbidity and burden (DELTA study)].
    Pélissolo A; André C; Chignon JM; Dutoit D; Martin P; Richard-Berthe C; Tignol J
    Encephale; 2002; 28(6 Pt 1):510-9. PubMed ID: 12506263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral, psycho-physiological and salivary cortisol modifications after short-term alprazolam treatment in patients with recent myocardial infarction.
    Pruneti C; Giusti M; Boem A; Luisi M
    Ital Heart J; 2002 Jan; 3(1):53-9. PubMed ID: 11899591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical effect of alprazolam and trazodone on bronchial asthmatics with anxiety disorder].
    Haida M; Itoh K
    Arerugi; 1997 Oct; 46(10):1058-71. PubMed ID: 9404094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of anxious-depressive syndromes with tofizopam].
    Novotný V; Molcan J; Sipkovská E; Knoíková M
    Act Nerv Super (Praha); 1979 Oct; 21(3):152-3. PubMed ID: 42263
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anxiety and depressive symptoms in patients treated due to haematologic malignancies].
    Małyszczak K; Tomasz W; Mazur G; Lindner K; Pyszel A; Kiejna A; Kuliczkowski K; Andrzejak R
    Psychiatr Pol; 2005; 39(1):33-40. PubMed ID: 15771152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzodiazepine use in an ambulatory elderly population: a 14-year overview.
    Stewart RB; Marks RG; Padgett PD; Hale WE
    Clin Ther; 1994; 16(1):118-24. PubMed ID: 7911401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse effects of benzodiazepines in psychiatric outpatients.
    Arbanas G; Arbanas D; Dujam K
    Psychiatr Danub; 2009 Mar; 21(1):103-7. PubMed ID: 19270632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Follow-up study of quality of life and treatment of eating disorder: dynamics of the depressive and anxiety symptoms].
    Banaś A; Januszkiewicz-Grabias A; Radziwiłłowicz P; Smoczyński S
    Psychiatr Pol; 2002; 36(6 Suppl):323-9. PubMed ID: 12647456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The acute effects of L-theanine in comparison with alprazolam on anticipatory anxiety in humans.
    Lu K; Gray MA; Oliver C; Liley DT; Harrison BJ; Bartholomeusz CF; Phan KL; Nathan PJ
    Hum Psychopharmacol; 2004 Oct; 19(7):457-65. PubMed ID: 15378679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of phospholipid liposomes in the treatment of neuropsychological disorders associated with the menopause: a double-blind, randomised, placebo-controlled study.
    Rachev E; Nalbansky B; Kolarov G; Agrosì M
    Curr Med Res Opin; 2001; 17(2):105-10. PubMed ID: 11759177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of alprazolam (xanax) in mental disorders in patients with left- and right hemispheric ischemic stroke].
    Ibadullaev ZP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(3):68-70. PubMed ID: 15071849
    [No Abstract]   [Full Text] [Related]  

  • 20. Socioeconomic correlates of generalized anxiety disorder and major depression in primary care: the GADIS II study (Generalized Anxiety and Depression Impact Survey II).
    Ansseau M; Fischler B; Dierick M; Albert A; Leyman S; Mignon A
    Depress Anxiety; 2008; 25(6):506-13. PubMed ID: 17595015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.